FrancophonIA/ELRC3.0 huggingface dataset:
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER 4x1, 10x1, 30x1 or 100x1 tablets
Maltese: FOLJA 4x1, 10x1, 30x1 jew 100x1 pilloli
English: Musculoskeletal, connective tissue and bone disorders
Maltese: Disturbi muskoluskeltrali, tat-tessut konnettiv u fl-għadam
English: In addition to clinical studies experience, adverse reactions have been spontaneously reported.
Maltese: reazzjonijiet avversi ġew ukoll irrapportati b'mod spontanju.
English: In addition, a subgroup analysis by age suggested that the benefit of clopidogrel in patients over 75 years was less than that observed in patients ≤75 years.
Maltese: sena kien inqas minn dak osservat f'pazjenti ≤75 sena.
English: Other concomitant therapy: Since clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of medicinal products that inhibit the activity of this enzyme would be expected to result in reduced drug levels of the active metabolite of clopidogrel.
Maltese: Peress li parti mill-metaboliżmu ta' clopidogrel għall-metabolit attiv tiegħu jsir minn CYP2C19, huwa mistenni li l-użu tal-prodotti mediċinali li jinibixxu l-attività ta' din l-enzima jwasslu għal tnaqqis fil livell tal-metabolit attiv ta' clopidogrel.
English: Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes in taste or loss of taste of food.
Maltese: infafet fil-ġilda; reazzjoni allerġika fil-ġilda; uġigħ fil-ħalq (stomatite); tnaqqis fil-pressjoni tad-demm; konfużjoni; alluċinazzjonijiet; uġigħ fil-ġogi; uġigħ muskolari; tibdil fit-togħma ta' l-ikel jew ma tibqax ittiegħem l-ikel.
English: Thrombolytics: the safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific thrombolytic agents and heparins was assessed in patients with acute myocardial infarction.
Maltese: Trombolitiċi: is-sigurta` tat-teħid flimkien ta' clopidogrel, sustanzi trombolitiċi speċifiċi għall-fibrina jew li m'humiex u heparins ġiet eżaminata f'pazjenti li kellhom infart mijokardijaku akut.
English: Bruising
Maltese: sturdament
English: Plavix 300-mg film-coated tablets are oblong, pink, engraved on one side with the number ‘300' and on the other side with the number ‘1332'.
Maltese: Il-pilloli miksija b'rita ta' Plavix 300 mg huma oblungi, ta' kulur roża,miksijin b'rita u bin-numru ‘300' imnaqqax fuq naħa waħda u n-numru ‘1332' imnaqqax fuq in-naħa l-oħra.
English: The prasugrel-only patients were continued on prasugrel for 11.5 months.
Maltese: Ilpazjenti li kienu fuq prasugrel biss komplew fuq prasugrel għal 11.5 xhur.
English: Plavix 75 mg film-coated tablets clopidogrel
Maltese: Plavix 75 mg pilloli miksijin b'rita clopidogrel
English: Recent myocardial infarction (MI), recent stroke or established peripheral arterial disease
Maltese: myocardial infarction ), u vaskularazzjoni urġenti mill-ġdid).
English: 2.4% to 19.1%; p=0.013), primarily due to a large reduction in the incidence of strokes.
Maltese: 38.3%; p=0.00001).
English: As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be discouraged (see section 4.5 for a list of CYP2C19 inhibitors, see also section 5.2).
Maltese: Bħala prekawzjoni, l-użu konkomitanti ta' inibituri qawwijin jew moderati ta' CYP2C19 għandu jiġu skoraġġut (ara sezzjoni 4. 5 għal lista ta' inibituri ta' CYP2C19, ara wkoll sezzjoni 5.2).
English: Rare side effect (may affect up to 1 in 1000 people): Vertigo, enlarged breasts in males.
Maltese: Effetti sekondarji rari (jistgħu jaffettwaw sa 1 minn kull 1000 persuna):
English: - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.
Maltese: Infart mijokardijaku akut b'segment ST elevat, flimkien ma' ASA f'pazjenti ittrattati bilmediċini u eliġibbli għat-terapija trombolitika.
English: EU/1/98/069/013 - Cartons of 28 film-coated tablets in all aluminium blisters EU/1/98/069/014 - Cartons of 50x1 film-coated tablets in all aluminium blisters EU/1/98/069/015 - Cartons of 84 film-coated tablets in all aluminium blisters EU/1/98/069/016 - Cartons of 100 film-coated tablets in all aluminium blisters EU/1/98/069/017 - Cartons of 30 film-coated tablets in all aluminium blisters EU/1/98/069/018 - Cartons of 90 film-coated tablets in all aluminium blisters EU/1/98/069/019 - Cartons of 14 film-coated tablets in all aluminium blisters EU/1/98/069/020 - Cartons of 7 film-coated tablets in all aluminium blisters
Maltese: EU/1/98/069/013 - Kaxex ta' 28 pillola miksija b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/014 - Kaxex ta' 50x1 pilloli miksijin b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/015 - Kaxex ta' 84 pillola miksija b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/016 - Kaxex ta' 100 pillola miksija b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/017 - Kaxex ta' 30 pillola miksija b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/018 - Kaxex ta' 90 pillola miksija b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/019 - Kaxex ta' 14-il pillola miksija b'rita fil-folji kollha kemm huma tal-aluminju EU/1/98/069/020 - Kaxex ta' 7 pilloli miksija b'rita fil-folji kollha kemm huma tal-aluminju
English: A crossover study in 40 healthy subjects, 10 each in the four CYP2C19 metaboliser groups (ultrarapid, extensive, intermediate and poor), evaluated pharmacokinetic and antiplatelet responses using 300 mg followed by 75 mg/day and 600 mg followed by 150 mg/day, each for a total of 5 days (steady state).
Maltese: Studju tat-tip crossover f'40 suġġett f'saħħtu, 10 f'kull wieħed mill-erba' gruppi ta' metabolizzaturi ta' CYP2C19 (estremament mgħaġġel, estensiv, intermedju u dgħajjef), evalwa r-rispons farmakokinetiku u dak kontra l-plejtlits b'300 mg segwita b'75 mg/jum u 600 mg segwita b'150
English: TOPIC (Timing Of Platelet Inhibition after acute Coronary syndrome) This randomized, open-label trial included ACS patients requiring percutaneous coronary intervention (PCI).
Maltese: Din il-prova open-label u magħmula b'mod arbitrarju kienet tinkludi pazjenti ACS li kellhom bżonn ta' intervent koronarju perkutaneju (PCI - percutaneous coronary intervention).
English: Secondary prevention of atherothrombotic events Clopidogrel is indicated in:
Maltese: Il-prevenzjoni sekondarja ta' avvenimenti aterotrombotiċi
English: Rash, pruritus, skin bleeding (purpura)
Maltese: fsada fil-ġilda (purpura)
English: Gastrointestinal and retroperitoneal haemorrhage with fatal outcome, pancreatitis, colitis (including ulcerative or lymphocytic colitis), stomatitis
Maltese: Emorraġija gastro intestinali u tar retroperitonew b'eżitu fatali, pankreatite, kolite
English: All patients were continued on aspirin and were followed for one year.
Maltese: Il-pazjenti kollha baqgħu fuq l aspirina u ġew segwiti għal sena.
English: Boosted anti-retroviral therapy (ART): HIV patients treated with boosted anti-retroviral therapies (ART) are at high risk of vascular events.
Maltese: Terapija antiretrovirali (ART-anti-retroviral therapy) msaħħa:
English: A pharmacodynamic interaction between clopidogrel and heparin is possible, leading to increased risk of bleeding.
Maltese: Huwa possibbli li jkun hemm interazzjoni farmakodinamika bejn clopidogrel u heparin, li jista'
English: PVC/PVDC/Aluminium or all aluminium perforated unit-dose blister packs in cardboard cartons containing 50x1 film-coated tablets.
Maltese: Pakketti ta' folji mtaqqbin ta' doża waħda tal-PVC/PVDC/Aluminju jew kollha kemm huma talaluminju f'kaxxi tal-kartun li fihom 50x1 pilloli miksijin b'rita.
English: <DD month YYYY>
Maltese: mnejn jingħata
English: - Plavix 75 mg film-coated tablets
Maltese: - Plavix 75 mg pilloli miksijin b'rita
English: In the intention to treat analysis, 939 events were observed in the clopidogrel group and 1,020 events with ASA (relative risk reduction (RRR) 8.7%, [95% CI: 0.2 to 16.4]; p=0.045), which corresponds, for every 1,000 patients treated for 2 years, to 10 [CI: 0 to 20] additional patients being prevented from experiencing a new ischaemic event.
Maltese: Fl-analiżi ta' l intenzjoni tal-kura, ġew osservati 939 avveniment fil-grupp ta' clopidogrel u 1 020 avveniment b'ASA (tnaqqis tar-riskju relattiv (RRR) ta' 8.7%, [95% CI: minn 0.2 għal 16.4]; p=0.045), li jikkorrispondi,
English: Thrombotic Thrombocytopenic Purpura (TTP) has been reported very rarely following the use of clopidogrel, sometimes after a short exposure.
Maltese: Ġiet irrapurtata Purpura Trombotika Tromboċitopenika (TTP) b'mod rari ħafna wara l-użu ta'
English: This statistically significant difference was mainly driven by fewer bleeding events, with no difference reported in ischaemic endpoints (p=0.36), while BARC ≥2 bleeding occurred less frequently in the de-escalated DAPT group (4.0%) versus 14.9% in the unchanged DAPT group (p<0.01).
Maltese: Din id-differenza statistikament sinifikanti kienet ikkawżata l-iżjed minħabba li kien hemm inqas avvenimenti ta' fsada ,mingħajr ma ġiet irrapportata ebda differenza fil-punti finali iskemiċi (p=0.36), waqt li BARC ≥2 episodji ta' fsada seħħ b'mod anqas frekwenti fil-grupp ta' DAPT
English: Clopidogrel is first metabolised to a 2-oxo-clopidogrel intermediate metabolite.
Maltese: 2-oxo-clopidogrel.
English: After single and repeated oral doses of 75 mg per day, clopidogrel is rapidly absorbed.
Maltese: Assorbiment Wara doża orali waħda u ripetuta ta' 75 mg kuljum, clopidogrel kien assorbit b'rata mgħaġġla.
English: It also contains: hydrogenated castor oil and lactose.
Maltese: Fiha ukoll: castor oil idroġenat u lactose .
English: - Plavix 300 mg film-coated tablets
Maltese: - Plavix 300 mg pilloli miksijin b'rita
English: 50x1 tablets in PVC/PVDC/Aluminium blisters or in all aluminium perforated unit-dose blisters.
Maltese: 6.4 Prekawzjonijiet speċjali għall-ħażna Fil-folji tal-PVC/PVDC/Aluminju, aħżen f'temperatura taħt 30°C.
English: Plavix 75 mg film-coated tablets
Maltese: Plavix 75 mg pilloli miksijin b'rita
English: Calendar days Mon
Maltese: KARTUNA TA' BARRA
English: In contrast, post-hoc analyses demonstrated statistically significant increases in the bleeding risk with the more potent P2Y12 inhibitors, occurring predominantly during the maintenance phase, after the first month post-ACS.
Maltese: F'kuntrast, analiżi post-hoc wera żidiet statistikament sinifikanti fir-riskju ta' fsada bl-inibituri aktar potenti ta' P2Y12 , li seħħew l-aktar fil-fażi ta' manteniment, wara l-ewwel xahar wara ACS.
English: Haematuria
Maltese: stomatite
English: Recent ischaemic stroke
Maltese: Ir-rilevanza klinika mhijiex magħrifa.
English: Fever
Maltese: Fertilità
English: Plavix 300 mg film-coated tablets
Maltese: Plavix 300 mg pilloli miksijin b'rita
English: Polska sanofi-aventis Sp. z o.o.
Maltese: Polska sanofi-aventis Sp. z o.o. Tel: +48 22 280 00 00
English: It is preferable not to take this product during pregnancy.
Maltese: Tqala u treddigħ Huwa preferibbli li ma tiħux dan il-prodott waqt it-tqala.
English: In patients with atrial fibrillation, clopidogrel should be given as a single daily dose of 75 mg. ASA (75-100 mg daily) should be initiated and continued in combination with clopidogrel (see section 5.1).
Maltese: F'pazjenti b'fibrillazzjoni atrijali, clopidogrel għandu jingħata bħala doża waħda kuljum ta' 75 mg. ASA (75-100 mg) għandu jinbeda u jitkompla jittieħed flimkien ma' clopidogrel (ara sezzjoni 5.1)
English: Core:
Maltese: Sími:
English: The prevalence of CYP2C19 alleles that result in intermediate and poor CYP2C19 metabolism differs according to race/ethnicity (see Pharmacogenetics).
Maltese: L-inċidenza tal-alleli ta' CYP2C19 li tirriżulta f'metaboliżmu intermedju u dgħajjef ta' CYP2C19
English: Sun
Maltese: L
English: 6 months; prior intracerebral hemorrhage; significant thrombocytopenia (platelet count < 50 x 109/l);
Maltese: <1/1,000); rari ħafna (<1/10,000), mhux magħruf (ma tistax tittieħed stima mid-data disponibbli).
English: Plavix is supplied in cardboard cartons containing: 7, 14, 28, 30, 84, 90 and 100 tablets in PVC/PVDC/Aluminium blisters or in all aluminium blisters
Maltese: - 7, 14, 28, 30, 84, 90 u 100 pilloli ġo folji tal-PVC/PVDC/Aluminju jew ġo folji magħmulin kollha mill-aluminju - 50x1 pilloli f'folji tal-PVC/PVDC/Aluminju jew f'folji mtaqqbin b'doża waħda kollha kemm huma ta' l-aluminju.
English: Plavix 75 mg film-coated tablets Pink, round, biconvex, engraved with «75» on one side and «1171» on the other side.
Maltese: Roża, tonda, konvessa miż-żewġ naħat, b' «75» imnaqqax fuq naħa waħda u «1171» imnaqqax fuq innaħa l-oħra.
English: How to store Plavix
Maltese: Kif gћandek tieћu Plavix
English: Although the administration of clopidogrel 75 mg/day did not modify the pharmacokinetics of S-warfarin or International Normalised Ratio (INR) in patients receiving long-term warfarin therapy, coadministration of clopidogrel with warfarin increases the risk of bleeding because of independent effects on hemostasis.
Maltese: Għalkemm l-għoti ta' clopidogrel 75 mg/jum ma mmodifikax il-farmakokinetika ta' S-warfarin jew il-Proporzjon
English: Fri
Maltese: ISEM
English: You should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as: o oral anticoagulants, medicines used to reduce blood clotting, o a non-steroidal anti-inflammatory medicine, usually used to treat painful and/or inflammatory conditions of muscle or joints, o heparin or any other injectable medicine used to reduce blood clotting, o ticlopidine, other antiplatelet agent, o a selective serotonin reuptake inhibitor (including but not restricted to fluoxetine or fluvoxamine), medicines usually used to treat depression, - omeprazole or esomeprazole, medicines to treat upset stomach, - fluconazole or voriconazole, medicines to treat fungal infections,
Maltese: - mediċini li jistgħu jżidu r-riskju li inti jkollok xi fsada bħal: o sustanzi kontra l-koagulazzjoni tad-demm li jittieħdu mill-ħalq, mediċini użati biex iraqqu d-demm, o mediċina anti-infjammatorja li mhijiex sterojde, normalment użata biex jiġi ittrattat l-uġigħ u/jew kundizzjonijiet infjammatorji tal- muskoli jew tal-ġogi,,
English: Excipients with known effect: Each film-coated tablet contains 12 mg of lactose and 13.2 mg of hydrogenated castor oil.
Maltese: Kull pillola miksija b'rita fiha 12 mg ta' lactose u 13.3 mg ta' castor oil idroġenat Għal-lista kompluta ta' eċċipjenti, ara sezzjoni 6.1.
English: In particular, in a post-hoc analysis in 2,172 patients (17% of the total CURE population) who underwent stent placement (Stent-CURE), the data showed that clopidogrel compared to placebo, demonstrated a significant RRR of 26.2% favouring clopidogrel for the co-primary endpoint (CV death, MI, stroke) and also a significant RRR of 23.9% for the second co-primary endpoint (CV death, MI, stroke or refractory ischaemia).
Maltese: imqabbel ma plaċebo, wera RRR sinifikanti ta' 26.2% favur clopidogrel għal punt ko-primarju ta' tmiem (mewt b' CV, MI, puplesija) u wkoll RRR sinifikanti ta' 23.9% għatt-tieni punt ko-primarju ta'
English: Although the clinical relevance of these findings is uncertain, there have been spontaneous reports of HIV-infected patients treated with ritonavir boosted ART, who have experienced re-occlusive events after de-obstruction or have suffered thrombotic events under a clopidogrel loading treatment schedule.
Maltese: Għalkemm ir-rilevanza klinika ta' dawn is-sejbiet mhijiex ċara, kien hemm rapporti spontanji ta' pazjenti infettati bl-HIV ittrattati b'ART imsaħħaħ b'ritonavir, li reġgħu kellhom avvenimenti ta' okklużjoni wara intervent ta' tneħħija ta' ostruzzjoni jew li sofrew minn avvenimenti trombotiċi waqt skeda ta' trattament ta' kkargar b'clopidogrel.
English: Package leaflet: Information for the user Plavix 300-mg film-coated tablets clopidogrel
Maltese: Jekk kellek uġigħ sever f'sidrek (anġina instabbli jew attakk tal-qalb), it-tabib jista' jagħtik 300 mg ta'
English: As with other oral P2Y12 inhibitors, co-administration of opioid agonists has the potential to delay and reduce the absorption of clopidogrel presumably because of slowed gastric emptying.
Maltese: Bħal ma jiġri ma' inibituri orali oħra ta' P2Y12, it-teħid fl-istess ħin ta' agonisti opjodi għandu lpotenzjal li jittardja u jnaqqas l-assorbiment ta' clopidogrel, wisq probabbli minħabba dewmien fliżvojtar gastriku.
English: Plavix 300 mg film-coated tablets This 300 mg tablet of clopidogrel is intended for use as a loading dose.
Maltese: Din il-pillola ta' 300 mg ta' clopidogrel hija intenzjonata għall-użu bħala doża ta' kkargar.
English: The expiry date refers to the last day of that month.
Maltese: Dawn jista' jkunu minħabba tnaqqis rari ta' xi ċelluli tad-demm.
English: The CURE study included 12,562 patients with non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), and presenting within 24 hours of onset of the most recent episode of chest pain or symptoms consistent with ischaemia.
Maltese: elevat (anġina instabbli jew infart mijokardijaku li mhux-mewġa-Q), u li ddaħħlu fl-istudju f'24 siegħa mill-iktar episodju reċenti ta' uġigħ fis-sider jew sintomi konsistenti ma' l-iskemija.
English: As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be discouraged (see sections 4.4 and 5.2).
Maltese: Bħala prekawzjoni, l-użu konkomitanti ta' inibituri qawwija jew moderati ta' CYP2C19 għandu jiġi skoraġġut (ara sezzjonijiet 4.4 u 5.2).
English: Not applicable
Maltese: RESPONSABBLI
English: Belgium Effik Benelux
Maltese: Effik Benelux
English: Laboratorios Aurobindo S.L.U.
Maltese: Laboratorios Aurobindo S.
English: Dienogest/Etinilestra diol Aurobindo
Maltese: Dienogest/Etinilest radiol Aurobindo
English: Mithra Pharmaceuticals Sa Midien
Maltese: Il-Ġermanja Mithra Pharmaceuticals Sa Midien
English: Dienogest/Etinilestra diol Cinfa
Maltese: Dienogest/Etinilest radiol Cinfa
English: Luxembourg Mithra Pharmaceuticals Sa Deltanogest
Maltese: Mithra Pharmaceuticals Sa Deltanogest
English: Gedeon Richter România S.A.
Maltese: Ir-Rumanija Gedeon Richter România S.A.
English: Dr. Kade - Besins Pharma Gmbh
Maltese: Il-Ġermanja Dr. Kade - Besins Pharma Gmbh
English: Zentiva Pharma
Maltese: Il-Ġermanja Zentiva Pharma
English: Hormosan Pharma Gmbh Luvyna
Maltese: Il-Ġermanja Hormosan Pharma Gmbh Luvyna
English: Pharma Gerke Arzneimittelvertriebs Gmbh
Maltese: Il-Ġermanja Pharma Gerke Arzneimittelvertriebs Gmbh
English: Mibe Gmbh Arzneimittel
Maltese: Il-Ġermanja Mibe Gmbh Arzneimittel
English: Exeltis Slovakia S.R.O.
Maltese: Is-Slovakkja Exeltis Slovakia S.R.O.
English: Aristo Pharma Gmbh (Art
Maltese: Il-Ġermanja Aristo Pharma Gmbh (Art 57) Aristelle
English: Exeltis Baltics Uab, Lithuania
Maltese: Exeltis Baltics Uab, Lithuania Diecyclen
English: Egis Pharmaceuticals Plc Omisson
Maltese: Egis Pharmaceuticals Plc
English: Sandoz Farmacéutica, S.A. Ceciliana
Maltese: Sandoz Farmacéutica, S.A.
English: Exeltis Germany Gmbh Velafee 21+7
Maltese: Velafee 21+7
English: Eurimpharm Arzneimittel Gmbh
Maltese: Il-Ġermanja Eurimpharm Arzneimittel Gmbh
English: Meda Pharma Gmbh & Co. Kg
Maltese: Il-Ġermanja Meda Pharma Gmbh & Co.
English: Sun-Farm Sp. Z.O.O.
Maltese: Sp. Z.O.O.
English: 1 A Pharma Gmbh
Maltese: Il-Ġermanja 1 A Pharma Gmbh
English: Exeltis Germany Gmbh Viola
Maltese: Exeltis Germany Gmbh
English: Kohlpharma Gmbh
Maltese: Il-Ġermanja Kohlpharma Gmbh
English: Ladeepharma Slovakia, S.R.O.
Maltese: Is-Slovakkja Ladeepharma Slovakia, S.R.O.
English: Velvet-Ratiopharm Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet
Maltese: Velvet-Ratiopharm Dienogest 2mg Pillola, Ethinylestradiol 0.
English: Luxembourg Ratiopharm Gmbh
Maltese: Il-Ġermanja Ratiopharm Gmbh
English: Emra-Med Arzneimittel Gmbh
Maltese: Il-Ġermanja Emra-Med Arzneimittel Gmbh Valette
English: Motion Ratiopharm Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet
Maltese: Motion Ratiopharm Dienogest 2mg Pillola, Ethinylestradiol 0.
English: Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet $ Placebo 0mg Tablet
Maltese: Dienogest 2mg Pillola, Ethinylestradiol 0.03mg Pillola $ Plaċebo 0mg Pillola
English: Jenapharm Gmbh & Co Kg Maxim
Maltese: Il-Ġermanja Jenapharm Gmbh & Co
English: Dienogest 2mg, Ethinylestradiol 0.03mg
Maltese: Dienogest 2mg, Ethinylestradiol 0.
English: Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet $ Lactose Monohydrate 60.9mg Tablet
Maltese: Dienogest 2mg Pillola, Ethinylestradiol 0.03mg Pillola $ Lactose Monohydrate 60.9mg Pillola
English: Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet $ Lactose 37.26mg Tablet
Maltese: Dienogest 2mg Pillola, Ethinylestradiol 0.03mg Pillola $ Lactose 37.26mg Pillola
English: Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet $ Lactose Anhydrous 37.26mg Tablet
Maltese: Dienogest 2mg Pillola, Ethinylestradiol 0.03mg Pillola $ Lactose Anhydrous 37.26mg Pillola
English: Placebo 0mg Tablet
Maltese: 03mg Pillola
English: Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet $ Lactose Monohydrate 55.5mg Tablet
Maltese: Dienogest 2mg Pillola, Ethinylestradiol 0.03mg Pillola $ Lactose Monohydrate 55.5mg Pillola
English: Dienogest 2mg Tablet, Ethinylestradiol 0.03mg Tablet $ Lactose Monohydrate 55mg Tablet
Maltese: Dienogest 2mg Pillola, Ethinylestradiol 0.03mg Pillola $ Lactose Monohydrate 55mg Pillola
English: Dienogest 2mg, Ethinylestradiol 0.03mg $ Lactose Anhydrous 37.26mg
Maltese: 03mg $ Lactose Anhydrous 37.26mg
English: Sandoz Pharmaceuticals D.D.
Maltese: Is-Slovakkja Sandoz Pharmaceuticals D.D. Foxinette Neo
English: Acis Arzneimittel Gmbh Dienogenance
Maltese: Il-Ġermanja Acis Arzneimittel Gmbh
English: Teva Pharma S.L.U
Maltese: Teva Pharma
English: Orifarm Gmbh
Maltese: Il-Ġermanja Orifarm Gmbh
English: J. Amer. Sci. 69, 4512-4522
Maltese: Sci. 69, 4512-4522
English: (1997), Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens, Veterinary Record, July 12, 141(2), p. 37-40
Maltese: H.(1997), Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens, Veterinary Record, July 12, 141(2), p. 37-40
English: 6.1 List of excipients
Maltese: 6.1 Lista ta' eċipjenti
English: INN & Strength
Maltese: INN &
English: Formed from a polyester/polyethylene/aluminium/polyethylene or a polyester/ polyethylene/aluminium/ionomer laminate.
Maltese: Iffurmat minn polyester/polyethylene/aluminju/polyethylene jew polyester/polyethylene/aluminju/pellikola jonomera.
English: Name
Maltese: ISEM
English: Tartaric acid
Maltese: Aċidu tartariku
English: 1 Pijpers, A. et al. (1991), Plasma levels of oxytetracycline, doxycycline, and monocycline in pigs after oral administration in feed.
Maltese: (1991), Plasma levels of oxytetracycline, doxycycline, and monocycline in pigs after oral administration in feed.
English: Bousquet et al. 19973 provides evidence of minimum inhibitory concentrations (MICs) of doxycycline against: P. multocida of 0.13 - 2.0 µg/ml (55 strains), A. pleuropneumoniae 0.25 - 2.0 µg/ml (59 strains), M. hyponeumoniae 0.016 - 2 µg/ml (26 strains).
Maltese: Bousquet et al. 19973 jipprovdu evidenza ta' konċentrazzjonijiet inibitorji minimi (MICs) ta' doxycycline kontra: P. multocida ta' 0.132.0 µg/ml (55 razza), A. pleuropneumoniae 0.25 - 2.0 µg/ml (59 razza), M. hyponeumoniae 0.016 - 2 µg/ml (26 razza).
English: LABELLING 10 x 100 g
Maltese: ITIKKETTJAR 10 x 100 g
English: 6 The ARBAO-II study, Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries form year 2002-2004, Acta Veterinaria Scandinavica 50(19) (2008)
Maltese: L-istudju ARBAO-II, L-Okkorrenza ta' reżistenza antimikrobjali fost il-patoġeni batteriċi u batterji indikaturi fil-majjali f'pajjiżi Ewropej differenti mis-snin 2002-2004, Acta Veterinaria Scandinavica 50(19) (2008)
English: ATC vet code: QJ 01 AA 02
Maltese: ATC kodiċi vett : QJ 01 AA 02 5.1 Kwalitajiet Farmakodinamiċi
English: PACKAGE SIZE 100 g (250 g, 500 g, 1 kg)
Maltese: DAQS TAL-PAKKETT 100 g (250 g, 500 g, 1 kg)